Pablo Castañeda, MD

Contact Information

  • Name: Pablo Castañeda
  • Degree: MD
  • Title / Position: Division Chief, Pediatric Orthopaedic Surgeon, NYU Hospital for Joint disease NYC / IHDI Medical Advisory Board Member
  • Place of Employment / Office Name: NYU Langone Medical Center, Hospital for Joint Disease
  • Street Address: 301 East 17th Street, Room 400b
  • City: New York
  • State/Province: New York
  • Zip/Postal code: 10003
  • Country: United States
  • Office phone number: NYU/ HJD 212-598-6624 or 212-598-2782
  • Office fax number: NYU/ HJD 646-794-1201
  • Medical or Surgical Specialty: Pediatric Orthopaedics, Orthopaedic Surgery

Professional Education and Memberships

  • Medical School: Anahuac University Medical School, Mexico City
  • Residency: The American British Cowdray Medical Center, Mexico City
  • Fellowship training:

    Nuffield Orthopaedic Centre Oxford – Adult Reconstructive Hip and Knee Surgery, Botnar Research Centre, University of Oxford – Prosthesis Design Research Fellow, Baylor College of Medicine Houston – Pediatric Orthopaedics

  • Certifications:

    United States Medical Licensing Examination (USMLE), Dirección General de Profesiones, Mexican General Directorate of Professional Activity, Mexican Board of Orthopaedic Surgery

  • Society Memberships (list up to four only):
    • Mexican Society of Pediatric Orthopedics (President 2013)
    • Mexican Society of Orthopedics
    • Pediatric Orthopedic Society of North America,
    • American Academy of Orthopaedic Surgeons
  • Academic contributions for DDH research or education including publications:
    • Castañeda P; Pediatric hip dysplasia and evaluation with ultrasound. Pediatric Health 2009; 3(5): 465-472.
    • Castañeda, P, Zaltz I; Hip, Pelvis, and Femur Disorders: Pediatrics, in Orthopaedic. Knowledge Update 10, American Academy of Orthopedic Surgeons AAOS, February, 2011.
    • Castañeda LP, Nualart HL, Pérez SMD, Cassis ZN; Estrategias para disminuir la reluxación después de una reducción en la displasia del desarrollo de la cadera (Strategies for reducing the rate of redislocation after reduction of a developmentally dislocated hip). Rev Mex Ortop Ped. 2013:15(1):40-46.
    • Castañeda LP, Iturbide SP; Evaluación de la perfusión de la cabeza femoral en el tratamiento de la displasia del desarrollo de la cadera (Evaluation of femoral head perfusion in the treatment of developmental dysplasia of the hip). Rev Mex Ortop Ped. 2013:15(1):47-52.

     

Practice Information

  • Age groups you are accepting new hip dysplasia patients: Infants and children, Adolescents, Adults
  • Call to Action Buttons

  • Email Sign Up

    Email Sign Up
  • Social Media Links

  • Translate Link

    Para ver en Español Click Aquí

  • SubNav Menu

  • Hippo CTA

  • Child CTA

  • Latest News

    Latest News

    Submit a Story

    Hip Dysplasia Survey

    Jun 26

    Are you a patient or parent/guardian of a child with Developme...

    Cannabis Compounds and Hip Dysplasia

    Jun 24

    Considering Cannabis Compounds for Hip Dysplasia Treatment? The...

    Should you wait to have a PAO until your arthritis...

    May 30

    There is often a question of how long it’s safe to postpone PAO surg...

  • Latest Stories

    Latest Stories

    Submit a Story

    Hayley

    Jun 19

     My Hip Dysplasia story is unusual because it isn't even mine. I...

    Miles

    Jun 12

    About two years ago, my 17 year old son started experiencing moderate ...

    Michele

    Jun 10

    I was born with bilateral hip dysplasia. My left hip is worse then my ...